In Lead-Up To MDUFMA II, Sen. Hatch Presses FDA On User Fee Trigger Issue
This article was originally published in The Gray Sheet
Executive Summary
Utah Republican Senator Orrin Hatch is pushing FDA to reconsider its apparent position on how device user fees should be activated on an annual basis under reauthorized legislation